Klaricid IV mg (PL /, Abbott Laboratories Ltd). No new or unexpected safety concerns arose from this application and it was therefore judged that. Indications, side effects, contraindications and other prescribing information for Klaricid IV on MIMS. Clarithromycin is indicated in: Lower respiratory tract infection: acute and chronic bronchitis and pneumonia;; Upper respiratory tract infection: sinusitis and.

Author: Mokazahn Mezitaxe
Country: Portugal
Language: English (Spanish)
Genre: Politics
Published (Last): 16 July 2018
Pages: 141
PDF File Size: 18.98 Mb
ePub File Size: 5.36 Mb
ISBN: 488-4-61949-367-4
Downloads: 45523
Price: Free* [*Free Regsitration Required]
Uploader: Malasar

Click here for US version.

Klaricid Iv Vials 1 (CLARITHROMYCIN – 500mg)

Always consult your healthcare provider to ensure the information displayed on this page klaricic to your personal circumstances. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices. Subscribe to receive email notifications whenever new articles are published. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. To view content sources and attributions, please refer to our editorial lv.

We comply with the HONcode standard for trustworthy health information – verify here.

Method of administration Refer to the summary of product characteristics for posology information. Clarithromycin should not be given as a bolus or an intramuscular injection. Compatibility with other IV additives has not been established. Store in the original container as the powder is sensitive to light.

See carton and vial for expiry date.

The product should not be used after this date. You may need jlaricid read it again. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

Klaricid Iv Vials 1 (Prescription item) (CLARITHROMYCIN – mg)

This includes any possible side effects not listed in the leaflet. What is in this leaflet: What Klaricid IV is and what it is used for 2. What you need to know before receiving Klaricid IV 3. How is Klaricid IV given? Possible side effects 5. How to store Klaricid IV 6. Contents of the pack and other information 1.

  DALEMARK QUARTET PDF

Klaricid belongs to a group of medicines called macrolide antibiotics.

Klaricid-I.V mg Inf – Clarithromycin – Price in Pakistan –

Antibiotics stop the growth of bacteria bugs that cause infections. Klaricid IV is used whenever an intravenous injection into the vein antibiotic is required to treat severe infections or, alternatively, if a patient cannot swallow Klaricid tablets. It is used to treat infections such as: Chest infections such as bronchitis and pneumonia 2. Throat and sinus infections 3.

Skin and tissue infections Klaricid IV is indicated in adults and children 12 years and older. Consult your doctor for advice on alternative medicines. Statins can cause rhabdomyolysis a condition which causes the breakdown of muscle tissue which can result in kidney damage and signs of myopathy muscle pain or muscle weakness should be monitored.

Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist before receiving the medicine as the safety of clarithromycin in pregnancy or breast-feeding is not known. Driving and Using Machines: Klaricid IV may make you feel dizzy or drowsy. If they affect you in this way do not drive, operate machinery or do anything that requires you to be alert.

Klaricid IV is prepared by your doctor or nurse by dissolving the powder in the vial in sterile water. The solution obtained is added to a larger volume of sterile liquid. Klaricid IV is given to you slowly through a needle, into your vein over a period of at least an hour. The recommended dose of Klaricid IV for adults and children over 12 years is 1. Your doctor will work out the correct dose for you. Children under 12 years should not be given Klaricid IV. Your doctor will prescribe another suitable medicine for your child.

If a child accidentally swallows some of this medicine, seek medical advice urgently. If you are given more Klaricid IV than you should have As Klaricid IV is given to you by a doctor, an overdose is unlikely but symptoms may include vomiting and stomach pains. Possible side effects Like all medicines, Klaricid IV can cause side effects although not everybody gets them.

  HEER BY WARIS SHAH IN PUNJABI PDF

If you suffer from any of the following at any time during your treatment tell your doctor immediately as your treatment may need to be stopped: Diarrhoea may occur over two months after treatment with clarithromycin, in which case you should still contact your doctor. This is a sign that you may have developed an allergic reaction. These are signs that your liver may have inflammation and not be working properly.

The frequency of this side effect is not known cannot klaridid estimated from the available data. If you suffer from myasthenia gravis a condition in which the muscles become weak and tire easilyclarithromycin may worsen these symptoms. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the Yellow Card Scheme at: By reporting side effects you can help provide more information on the safety of this medicine. How to store Klaricid IV Keep out of the sight and reach of children Do not use after the expiry date on the carton and vial.

Store in the original klagicid. The other ingredients are; lactobionic acid and sodium hydroxide. This medicinal product contains less than 23mg sodium 1mmol per mg i. What Klaricid IV looks like and contents of the pack Klaricid IV is a white to off-white caked, lyophilized powder available in vials containing When made up with Water for Injections, each millilitre ml of solution contains ig of clarithromycin.

Marketing Authorisation Holder and Manufacturer: This leaflet was last revised in February Latest Drug Information Updates. Ultomiris Ultomiris ravulizumab-cwvz is a long-acting C5 complement inhibitor for the treatment of paroxysmal Xospata Xospata gilteritinib is a kinase inhibitor indicated for the treatment of patients who have relapsed or Daurismo Daurismo glasdegib is klraicid hedgehog pathway inhibitor indicated for the combination treatment of adult Vitrakvi Vitrakvi larotrectinib is an oral selective tropomyosin receptor kinase TRK inhibitor for the treatment